文献速递外周动脉疾病

最佳药物治疗标志物与间歇性跛行择期血运重建后肢体结局改善相关

Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication.
PubMed 文献 · J Vasc Surg · 2024-08-27

基于血管质量倡议(2010-2020)数据,纳入39,088例间歇性跛行择期血运重建患者,按术前抗血小板、他汀及不吸烟状态分为完全、部分和无最佳药物治疗(OMT)三组。完全OMT较无OMT显著降低1年再干预(aOR 0.72)和主要不良肢体事件(MALE,aOR 0.70)的调整比值比。

要点

  • 完全OMT组1年再干预率5.3%、MALE率5.6%,均低于无OMT组的8.3%和8.8%(P < .001)。
  • 完全OMT较无OMT降低再干预调整比值比28%(aOR 0.72,95%CI 0.59-0.88)。
  • 完全OMT较无OMT降低MALE调整比值比30%(aOR 0.70,95%CI 0.58-0.85)。

核心结论

  • 术前OMT是一种使用不足但可改变的风险因素,与间歇性跛行患者1年再干预和MALE改善相关。
  • 血管外科医生处于独特位置,可在血运重建前启动并维持间歇性跛行患者的OMT以优化结局。

研究设计与样本

  • 使用血管质量倡议(2010-2020)数据,识别接受择期腔内、杂交和开放手术的间歇性跛行患者。
  • 术前抗血小板、他汀和不吸烟状态定义OMT组分,分为完全(全部组分)、部分(1-2个组分)和无OMT三组。
  • 共纳入39,088例患者,其中完全OMT 14,907例(38.1%)、部分OMT 22,054例(56.4%)、无OMT 2,127例(5.4%)。
  • 主要结局为1年再干预,次要结局包括MALE和与OMT使用相关的因素,采用多变量逻辑回归生成调整比值比(aOR)。

主要发现

  • 任何OMT患者更常见高龄、更多心血管疾病和糖尿病(P < .0001)。
  • 无OMT患者更可能为黑人或有Medicare或Medicaid(P < .05)。
  • 观察到的1年再干预率:完全OMT 5.3%、部分OMT 6.1%、无OMT 8.3%(P < .001)。
  • 观察到的MALE率:完全OMT 5.6%、部分OMT 6.3%、无OMT 8.8%(P < .001)。
  • 完全OMT较无OMT显著降低再干预调整比值比28%(aOR 0.72,95%CI 0.59-0.88)和MALE调整比值比30%(aOR 0.70,95%CI 0.58-0.85)。

临床怎么用

  • 作者认为术前OMT与间歇性跛行患者择期血运重建后1年再干预和MALE改善相关。
  • 作者指出血管外科医生可在血运重建前启动并维持OMT以优化患者结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal medical therapy (OMT) is a modifiable factor that decreases mortality and cardiovascular events in patients with severe peripheral arterial disease. We hypothesized that preintervention OMT would be associated with improved 1-year reintervention and major adverse limb event (MALE) rates after elective endovascular revascularization for intermittent claudication (IC). METHODS: Using the Vascular Quality Initiative (2010-2020), we identified patients with IC undergoing elective endovascular, hybrid, and open surgical interventions. Preoperative antiplatelet, statin, and nonsmoking status defined OMT components and created three groups: complete (all components), partial (1-2 components), and no OMT. The primary outcome was 1-year reintervention. Secondary outcomes included MALE and factors associated with OMT usage. Multivariable logistic regression generated adjusted odds ratios (aOR). RESULTS: There were 39,088 patients (14,907 [38.1%] complete, 22,054 [56.4%)] partial, 2127 [5.4%] no OMT) who met our criteria. Patients with any OMT were more frequently older with more cardiovascular diseases and diabetes (P < .0001). Patients without OMT were more likely to be Black or with Medicare or Medicaid (P < .05). Observed 1-year reintervention (5.3% complete OMT, 6.1% partial OMT, 8.3% no OMT; P < .001) and MALE (5.6% complete OMT, 6.3% partial OMT, 8.8% no OMT; P < .001) were decreased by partial or complete OMT compared with no OMT. Complete OMT significantly decreased the adjusted odds of reintervention and MALE by 28% (aOR, 0.72, 95% confidence interval [95% CI], 0.59-0.88) and 30% (aOR, 0.70; 95% CI, 0.58-0.85), respectively, compared with no OMT. Partial OMT decrease the adjusted odds of reintervention and MALE by 24% (aOR, 0.76; 95% CI, 0.63-0.92) and 26% (aOR, 0.74; 95% CI, 0.62-0.89), respectively. CONCLUSIONS: Preintervention OMT is an underused, modifiable risk factor associated with improved 1-year reintervention and MALE. Vascular surgeons are uniquely positioned to initiate and maintain OMT in patients with IC before revascularization to optimize patient outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jarosinski MC, Hafeez MS, Sridharan ND, et al. Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication. J Vasc Surg. 2024. PMID: 39208918. doi:10.1016/j.jvs.2024.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。